Dr. Beau Wangtrakuldee, a Ph.D, Amorsui

AmorSui Secures $3.5M Seed Funding to Transform Sustainable Medical Supplies

AmorSui, an innovative leader in sustainable personal protective equipment (PPE), has announced the completion of a $3.5 million seed funding round. This strategic investment, led by Gold House Ventures, The MBA Fund, and The Rev Up Fund, will fuel the company’s mission to enhance the safety and environmental responsibility of medical supplies. AmorSui aims to…

Read More

Noze Receives Historic $5M Investment from Bill & Melinda Gates Foundation to Advance Breath-Based Diagnostics

Noze, the innovative leader in breath-based diagnostic technology, has secured a transformative $5 million equity investment from the Bill & Melinda Gates Foundation. This groundbreaking funding is notable as it represents the Gates Foundation’s inaugural equity investment in a Canadian enterprise. The new investment, part of an extended funding round, builds on previous grants totaling…

Read More

FOSSA Systems Secures €6.3 Million to Expand IoT Satellite Constellation for Global Industrial Applications

FOSSA Systems, an innovative leader in space technology based in Madrid, has successfully closed a Series A funding round, raising €6.3 million to advance its pioneering IoT satellite constellation. This funding round was co-led by Indico Capital Partners and Nabtesco Technology Ventures, with additional participation from Newmind Venture and Sabadell Venture Capital. The investment will…

Read More

HERO Software Secures €40 Million to Propel Digital Transformation in European Tradesmen SMEs

Hanover-based HERO Software has achieved a significant milestone in its journey to revolutionize the tradesmen SME sector across Europe. The company, known for its innovative SaaS platform tailored to the needs of tradesmen in Germany, Austria, and Switzerland, has secured €40 million in Series B funding. This investment, led by Eight Roads Ventures with participation…

Read More

Excellergy Raises $70M to Rewrite the Allergy Playbook with Trifunctional Biologics

A new force has entered the allergy‑therapeutics arena. Excellergy has announced a bold $70 million Series A round designed to advance its lead candidates—“trifunctional” Effector Cell Response Inhibitors (ECRIs)—toward clinical proof. The molecules aim to simultaneously strip IgE from bound immune cells, neutralize free IgE, and tamp down the receptor expression that fuels allergic cascades….

Read More

Freeflow Ventures Secures $90 Million to Drive Early Stage Deep Tech Innovations

In a significant move bolstering its commitment to advancing science-driven solutions, Freeflow Ventures has announced the successful raise of $90 million in funding. This includes $50 million from its Fund Two and Opportunity Fund, complementing its existing $25 million Fund One and Special Purpose Vehicles (SPVs). Amidst a challenging venture capital landscape, Freeflow’s doubled fundraising…

Read More

Zinnia Secures $300 Million in Strategic Financing to Transform Life and Annuity Market

In a significant move poised to reshape the life and annuity (L&A) insurance technology landscape, Zinnia, a leading innovator in the sector, has successfully raised $300 million in strategic financing from Vista Credit Partners, a subsidiary of Vista Equity Partners. This funding marks a pivotal moment for Zinnia, enabling it to accelerate its market penetration…

Read More

Stimy AI Secures $425K to Revolutionize Personalized Math Learning

In a significant boost for educational technology, Stimy AI has successfully raised $425,000 in Pre-Seed funding, setting the stage for its innovative math learning app aimed at supporting students worldwide. Catering to learners aged 10 to 18, the app employs cutting-edge AI technology to provide tailored assistance in math, helping users tackle homework challenges and…

Read More